Cultured AFB Antitubercular DST Rapid 11 Drugs Panel Test
Comprehensive Tuberculosis Drug Sensitivity Testing
The Cultured AFB Antitubercular DST Rapid 11 Drugs Panel Test represents a breakthrough in tuberculosis management, providing comprehensive drug sensitivity profiling for Mycobacterium tuberculosis complex. This advanced diagnostic tool is essential for combating the growing challenge of drug-resistant tuberculosis strains that threaten public health worldwide.
What This Test Measures and Detects
This sophisticated panel evaluates the sensitivity of tuberculosis bacteria to 11 critical antitubercular medications:
- First-line drugs: Streptomycin, Isoniazid, Rifampicin, Ethambutol, Pyrazinamide
- Second-line drugs: Clofazimine, Ethionamide, Capreomycin, Kanamycin, Amikacin, Ofloxacin
Using automated fluorescent technology, the test determines whether the tuberculosis bacteria in your sample are susceptible or resistant to each medication, providing crucial information for effective treatment planning.
Who Should Consider This Test
This test is particularly important for individuals experiencing:
- Persistent cough lasting more than 3 weeks
- Unexplained weight loss and fatigue
- Night sweats and fever
- Chest pain and breathing difficulties
- Previous tuberculosis diagnosis with poor treatment response
- Contact with drug-resistant TB patients
- HIV co-infection with suspected TB
- Return from regions with high drug-resistant TB prevalence
Key Benefits of the 11-Drug Panel Test
- Comprehensive Resistance Profiling: Evaluates resistance across multiple drug classes
- Personalized Treatment Planning: Enables targeted therapy based on specific resistance patterns
- Prevention of Treatment Failure: Identifies ineffective medications before treatment initiation
- Reduced Side Effects: Avoids unnecessary exposure to ineffective drugs
- Cost-Effective Management: Prevents wasted resources on ineffective treatments
- Public Health Protection: Helps contain drug-resistant TB strains
Understanding Your Test Results
Your results will indicate susceptibility or resistance to each of the 11 tested medications:
- Susceptible: The medication is likely to be effective against your TB strain
- Resistant: The medication is unlikely to be effective, requiring alternative treatment options
- Intermediate: The medication may be effective at higher doses or in combination with other drugs
Your physician will use these results to design a customized treatment regimen that targets your specific TB strain effectively while minimizing side effects and treatment duration.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Cultured AFB Antitubercular DST Rapid 11 Drugs Panel Test | $388 USD | $550 USD |
Nationwide Availability
We have diagnostic centers conveniently located across major US cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our facilities are equipped with state-of-the-art technology and staffed by experienced professionals dedicated to providing accurate and timely results.
Take Control of Your Tuberculosis Treatment
Don’t let drug-resistant tuberculosis compromise your health. Our comprehensive 11-drug panel test provides the critical information needed to develop an effective treatment strategy. With results available in just 21 days and samples accepted daily until 3:30 PM, getting the answers you need has never been more convenient.
Ready to get started? Book your test today or call our dedicated healthcare line at +1(267) 388-9828 for immediate assistance and personalized guidance.
